Clinical trial designs for the approval of rare cancer drugs in Japan

被引：0

作者：

Noguchi, E. ^{[1
]}

Yonemori, K. ^{[1
]}

Shimoi, T. ^{[1
]}

Yunokawa, M. ^{[1
]}

Okuma, H. S. ^{[2
]}

Kawachi, A. ^{[2
]}

Kitano, A. ^{[3
]}

Nishikawa, T. ^{[2
]}

Shimomura, A. ^{[2
]}

Shimizu, C. ^{[2
]}

Takiguchi, Y. ^{[4
]}

Kawai, A. ^{[5
]}

Fujiwara, Y. ^{[2
]}

Tamura, K. ^{[2
]}

机构：

[1] Natl Canc Ctr, Rare Canc Ctr, Breast & Med Oncol, Tokyo, Japan

[2] Natl Canc Ctr, Breast & Med Oncol, Tokyo, Japan

[3] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan

[4] Chiba Univ, Grad Sch Med, Med Oncol, Chiba, Japan

[5] Natl Canc Ctr, Rare Canc Ctr, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

154P

引用

页数：1

共 50 条

[21] Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
Bogaerts, Jan
Sydes, Matthew R.
Keat, Nicola
McConnell, Andrea
Benson, Al
Ho, Alan
Rotha, Arnaud
Fortpied, Catherine
Eng, Cathy
Peckitt, Clare
Coens, Corneel
Pettaway, Curtis
Arnold, Dirk
Hall, Emma
Marshall, Ernie
Sclafani, Francesco
Hatcher, Helen
Earl, Helena
Ray-Coquard, Isabelle
Paul, James
Blay, Jean-Yves
Whelan, Jeremy
Panageas, Kathy
Wheatley, Keith
Harrington, Kevin
Licitra, Lisa
Billingham, Lucinda
Hensley, Martee
McCabe, Martin
Patel, Poulam M.
Carvajal, Richard
Wilson, Richard
Glynne-Jones, Rob
McWilliams, Rob
Leyvraz, Serge
Rao, Sheela
Nicholson, Steve
Filiaci, Virginia
Negrouk, Anastassia
Lacombe, Denis
Dupont, Elisabeth
Pauporte, Iris
Welch, John J.
Law, Kate
Trimble, Ted
Seymour, Matthew
EUROPEAN JOURNAL OF CANCER, 2015, 51 (03) : 271 - 281
[22] Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation
Puthumana, Jeremy
Wallach, Joshua D.
Ross, Joseph S.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (03): : 301 - 303
[23] Clinical Trial Designs
Nair, Brijesh
INDIAN DERMATOLOGY ONLINE JOURNAL, 2019, 10 (02) : 193 - 201
[24] Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network
Reiko Shimizu
Katsuhisa Ogata
Akemi Tamaura
En Kimura
Maki Ohata
Eri Takeshita
Harumasa Nakamura
Shin’ichi Takeda
Hirofumi Komaki
BMC Health Services Research, 16
[25] Pre-approval and post-approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
Bloem, Lourens T.
Bot, Rosa E.
Mantel-Teeuwisse, Aukje K.
van der Elst, Menno E.
Sonke, Gabe S.
Klungel, Olaf H.
Leufkens, Hubert G. M.
Hoekman, Jarno
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2169 - 2179
[26] Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network
Shimizu, Reiko
Ogata, Katsuhisa
Tamaura, Akemi
Kimura, En
Ohata, Maki
Takeshita, Eri
Nakamura, Harumasa
Takeda, Shin'ichi
Komaki, Hirofumi
BMC HEALTH SERVICES RESEARCH, 2016, 16
[27] Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer
Kesselheim, Aaron S.
Myers, Jessica A.
Avorn, Jerry
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2320 - 2326
[28] Patient access to experimental drugs and AIDS clinical trial designs: Ethical issues
Schuklenk, U
Hogan, C
CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 1996, 5 (03) : 400 - 409
[29] Window of opportunity clinical trial designs to study cancer metabolism
Francesca Aroldi
Simon R. Lord
British Journal of Cancer, 2020, 122 : 45 - 51
[30] Window of opportunity clinical trial designs to study cancer metabolism
Aroldi, Francesca
Lord, Simon R.
BRITISH JOURNAL OF CANCER, 2020, 122 (01) : 45 - 51

← 1 2 3 4 5 →